The inability to generate fully undifferentiated human iPS cells in vitro may contribute to inefficient and inconsistent differentiation of the cells. An Israeli team thinks a small molecule and cytokine cocktail capable of maintaining human cells in a more fully undifferentiated state could solve the problem.